Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-08

Clinical Trial Update: DMT310-005 Topical in the Treatment of Acne Rosacea [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for DMT310-005 topical treatment in acne rosacea is reported with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DMT310-005

Snippet

Sponsor: Dermata Therapeutics | Conditions: Acne Rosacea | Phase 2 | Status: UNKNOWN